Role of lncRNA NR2F1-AS1 and lncRNA H19 Genes in Hepatocellular Carcinoma and Their Effects on Biological Function of Huh-7

References

• Pauline P, Boris G, Sophie G, et al. Intra-arterial idarubicin_lipiodol without embolization can provide prolonged complete response in hepatocellular carcinoma: a case report. J Oncol Pharm Pract. 2020;26:507–510. doi:10.1177/107815521986142231315548
   PubMed Web of Science ®Google Scholar
• Wanshui Y, Jing S, Ma Y, et al. A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women. Int J Cancer. 2020;146:1241–1249. doi:10.1002/ijc.3242331116416
   PubMed Web of Science ®Google Scholar
• Shao-Jiao M, Peng-Fei Y, Liu Y-P, et al. BCLAF1 promotes cell proliferation, invasion and drug-resistance though targeting lncRNA NEAT1 in hepatocellular carcinoma. Life Sci. 2020;242:242: 117177. doi:10.1016/j.lfs.2019.117177
   Web of Science ®Google Scholar
• Jianchu W. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway. Biomed Pharmacother. 2019;120:109551. doi:10.1016/j.biopha.2019.10955131648164
   PubMed Web of Science ®Google Scholar
• Meiling L, Yu X, Lin L. ATGL promotes the proliferation of hepatocellular carcinoma cells via the p-AKT signaling pathway. J Biochem Mol Toxicol. 2019;33:e22391. doi:10.1002/jbt.2239131476254
   PubMed Web of Science ®Google Scholar
• Yong J, Wenlei Z, You S, Li M, Lei L, Chen L. A nomogram for predicting depression in patients with hepatocellular carcinoma: an observational cross-sectional study. Int J Psychiatry Clin Pract. 2019;23:273–280. doi:10.1080/13651501.2019.161977731124729
   PubMed Web of Science ®Google Scholar
• Hande T, Ezgi B. lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells. Cell Commun Signal. 2020;18:110. doi:10.1186/s12964-020-00602-032650779
   PubMed Web of Science ®Google Scholar
• Jin LL, Jin Y, Yang H. Network of clinically-relevant lncRNAs-mRNAs associated with prognosis of hepatocellular carcinoma patients. Sci Rep. 2020;10:11124. doi:10.1038/s41598-020-67742-832636408
   PubMed Web of Science ®Google Scholar
• Wu J-H, Xu K, Liu J-H, et al. LncRNA MT1JP inhibits the malignant progression of hepatocellular carcinoma through regulating AKT. Eur Rev Med Pharmacol Sci. 2020;24:6647–6656. doi:10.26355/eurrev_202006_2165132633354
   PubMed Web of Science ®Google Scholar
• Yongzi X, Yanhui L. Long non‑coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR‑675. Oncol Rep. 2020;44:165–173. doi:10.3892/or.2020.760832627034
   PubMed Web of Science ®Google Scholar
• Xuesong G. Overexpression of long noncoding RNAs (lncRNA) NF-κβ-interacting long noncoding RNA (NKILA) in ankylosing spondylitis is correlated with transforming growth factor β1 (TGF-β1), active disease and predicts length of treatment. Med Sci Monit. 2019;25:4244–4249. doi:10.12659/MSM.91381331173579
   PubMed Web of Science ®Google Scholar
• Lei W, Shanshan Z, Y U M. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4. Pharmazie. 2019;74:295–300. doi:10.1691/ph.2019.890531109400
   PubMed Web of Science ®Google Scholar
• Evodie P, Clément L, Collette J, et al. H19Enhancement of breast cancer cell aggressiveness by lncRNA and its mir-675 derivative: insight into shared and different actions. Cancers. 2020;12:. doi:10.3390/cancers12071730
   Web of Science ®Google Scholar
• Jie P, Fang H, Zhu W, et al. lncRNA nr2f1-as1 regulates mir-17/sik1 axis to suppress the invasion and migration of cervical squamous cell carcinoma cells. Reprod Sci. 2020;27:1534–1539. doi:10.1007/s43032-020-00149-y31994002
   PubMed Web of Science ®Google Scholar
• Takeshi O, Nakamasa H, Masamichi T. Clinical outcomes of brain metastases from hepatocellular carcinoma: a multicenter retrospective study and a literature review. Int J Clin Oncol. 2018;23:1095–1100. doi:10.1007/s10147-018-1312-529968168
   PubMed Web of Science ®Google Scholar
• Jiangshan L, Xiaolin Z, Lu Y, Hao S, Zhang Z, Yang Y. Expression and significance of lncRNA-MINCR and cdk2 mRNA in primary hepatocellular carcinoma. Comb Chem High Throughput Screen. 2019;22:201–206. doi:10.2174/138620732266619040415102030947664
   PubMed Web of Science ®Google Scholar
• Ling L, Jingjing C, Cao M, Wang J, Wang S. Cao Mengyao NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells. Cancer Chemother Pharmacol. 2019;84:1303–1314. doi:10.1007/s00280-019-03965-531555866
   PubMed Web of Science ®Google Scholar
• Yan S. Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5. J Cell Physiol. 2020;235:2963–2972. doi:10.1002/jcp.2920231538334
   PubMed Web of Science ®Google Scholar
• Aimin L, Saurav M, Haidan L, Jia P, Lee D-F, Zhao Z. H19, a long non-coding RNA, mediates transcription factors and target genes through interference of microRNAs in pan-cancer. Mol Ther Nucleic Acids. 2020;21:180–191. doi:10.1016/j.omtn.2020.05.02832585626
   PubMedGoogle Scholar
• Qiang C, Li P, Cao P. H19Genetic variant in long non-coding RNA modulates its expression and predicts renal cell carcinoma susceptibility and mortality. Front Oncol. 2020;10:785. doi:10.3389/fonc.2020.0078532509581
   PubMed Web of Science ®Google Scholar
• Junyi L, Haozhuo X, Guangming D, He T, Huang W. Recombinant adenovirus (AdEasy system) mediated exogenous expression of long non-coding RNA H19 (lncRNA H19) biphasic regulating osteogenic differentiation of mesenchymal stem cells (MSCs). Am J Transl Res. 2020;12:1700–1713.32509170
   PubMed Web of Science ®Google Scholar
• Shenglong L, Zheng K, Pei Y, Wang W, Zhang X. NR2F1-AS1Long noncoding RNA enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p. Aging. 2019;11:11609–11623. doi:10.18632/aging.10256331801112
   PubMedGoogle Scholar
• Xianjuan S, Yajing X, Hui C, Wang X, Ju S. Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma. Ann Clin Biochem. 2018;55:478–484. doi:10.1177/000456321774190829065698
   PubMed Web of Science ®Google Scholar
• Ren P, Zhang H. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT. Eur Rev Med Pharmacol Sci. 2020;24:3686–3693. doi:10.26355/eurrev_202004_2083132329844
   PubMed Web of Science ®Google Scholar
• Shibo Z, Jingqi Z, Yanhong C. Long non-coding RNA HOXA11-AS upregulates Cyclin D2 to inhibit apoptosis and promote cell cycle progression in nephroblastoma by recruiting forkhead box P2. Am J Cancer Res. 2020;10:284–298.32064168
   PubMed Web of Science ®Google Scholar
• Feng G, Fu Q, Wang Y, Sui G. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/ CCND1 axis. J Cell Mol Med. 2019;23:5907–5919. doi:10.1111/jcmm.1438631304680
   PubMed Web of Science ®Google Scholar
• Yuxian W, Yang Z, Jie H, Sun H, Jin Z. Long non-coding RNA H19 mediates ovarian cancer cell cisplatin-resistance and migration during EMT. Int J Clin Exp Pathol. 2019;12:2506–2515.31934077
   PubMed Web of Science ®Google Scholar
• Feng W, Long R, Zhengkui Z. LncRNA H19-Derived miR-675-3p promotes epithelial-mesenchymal transition and stemness in human pancreatic cancer cells by targeting the STAT3 pathway. J Cancer. 2020;11:4771–4782. doi:10.7150/jca.4483332626524
   PubMed Web of Science ®Google Scholar